Retour
26
Également cotée sous
RMSYF
OTC
Fourchette du Jour
6,55 €
6,98 €
Fourchette 52 Semaines
4,31 €
7,18 €
Volume
8
Moyenne 50J / 200J
6,52 €
/
5,80 €
Clôture Précédente
6,98 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 267,3 | 0,3 |
| P/B | 1,3 | 2,9 |
| ROE % | 0,5 | 3,7 |
| Net Margin % | 0,1 | 3,8 |
| Rev Growth 5Y % | 8,3 | 10,0 |
| D/E | 2,4 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2027 |
0,46 €
0,46 € – 0,48 €
|
21 B | 1 |
| FY2026 |
0,40 €
0,40 € – 0,41 €
|
20 B | 1 |
Points Clés
Revenue grew 8,27% annually over 5 years — modest growth
Earnings declined -97,30% over the past year
ROE of 0,48% is below average
Debt/Equity of 2,41 — high leverage
Generating 704,20M in free cash flow
P/E of 267,29 — premium valuation
Croissance
Revenue Growth (5Y)
8,27%
Revenue (1Y)6,09%
Earnings (1Y)-97,30%
FCF Growth (3Y)10,32%
Qualité
Return on Equity
0,48%
ROIC3,81%
Net Margin0,14%
Op. Margin4,93%
Sécurité
Debt / Equity
2,41
Current Ratio0,90
Interest Coverage2,60
Valorisation
P/E Ratio
267,29
P/B Ratio1,28
EV/EBITDA20,39
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6,09% | Revenue Growth (3Y) | 8,63% |
| Earnings Growth (1Y) | -97,30% | Earnings Growth (3Y) | -71,63% |
| Revenue Growth (5Y) | 8,27% | Earnings Growth (5Y) | -51,92% |
| Profitability | |||
| Revenue (TTM) | 17,67B | Net Income (TTM) | 24,00M |
| ROE | 0,48% | ROA | 0,11% |
| Gross Margin | 77,34% | Operating Margin | 4,93% |
| Net Margin | 0,14% | Free Cash Flow (TTM) | 704,20M |
| ROIC | 3,81% | FCF Growth (3Y) | 10,32% |
| Safety | |||
| Debt / Equity | 2,41 | Current Ratio | 0,90 |
| Interest Coverage | 2,60 | Dividend Yield | 0,02% |
| Valuation | |||
| P/E Ratio | 267,29 | P/B Ratio | 1,28 |
| P/S Ratio | 0,36 | PEG Ratio | -3,42 |
| EV/EBITDA | 20,39 | Dividend Yield | 0,02% |
| Market Cap | 6,42B | Enterprise Value | 17,75B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 17,67B | 16,66B | 14,98B | 13,18B | 12,86B |
| Net Income | 24,00M | 888,70M | 298,10M | 274,00M | 449,00M |
| EPS (Diluted) | 0,03 | 0,97 | 0,31 | 0,29 | 0,48 |
| Gross Profit | 13,67B | 2,01B | 1,27B | 900,60M | 832,80M |
| Operating Income | 870,50M | 833,20M | 1,64B | 230,60M | 1,59B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 22,48B | 20,89B | 21,13B | 19,58B | 19,39B |
| Total Liabilities | 16,77B | 15,37B | 16,30B | 15,06B | 14,83B |
| Shareholders' Equity | 5,02B | 4,90B | 4,15B | 3,93B | 4,03B |
| Total Debt | 12,12B | 10,94B | 11,89B | 10,70B | 10,55B |
| Cash & Equivalents | 784,40M | 662,30M | 656,10M | 314,20M | 2,96B |
| Current Assets | 4,04B | 3,87B | 3,90B | 3,29B | 5,35B |
| Current Liabilities | 4,47B | 4,18B | 3,81B | 3,75B | 3,72B |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#393 of 618
Activité Récente
Entré
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026